Endometrial cancer

Kimberly K. Leslie, University of Iowa
K. W. Thiel
Michael J. Goodheart, University of Iowa
Koen De Geest, University of Iowa
Y. Jia
S. Yang


Despite the questions and barriers, the incorporation of molecular therapy into treatment regimens in endometrial cancer is an exciting area of investigation with the potential to improve outcomes. Outside of the development of a reliable screening test for endometrial cancer, converting the disease to a chronic state and improving progression-free survival is our best hope to reverse the concerning trend of decreasing 5-year survival for this disease.